IPO India Information (BSE / NSE)

Thursday, May 22, 2014

Glenmark Pharma: An Fundamental+ Technical View

Fundamentals:
The stock is a buzz in every fundamental analyst perspective. And I personally had a look at this industry. And the company is performing good in Indian market majorly capturing heat, breathing, anti-infection and skin segment. All segments are performing a single digit growth (1-5%) yoy apart skin(which is giving +8% growth). I feel the stock had consolidated more than its value, after making a yearly high in recent days.

Technicals:
The stock can currently give a 14% return within few months. And the stock had bullish crossover of (100 & 200DMA). It has also withstood and sharp correction recently, currently the stock has shown a reversal at its support i.e @510. As per my analysis the stock is potentially good in Indian market. And 550 &610 can stand a resistance. This stock can surly be a multibagger if its quarterly & yearly performance is showing the same growth.